Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06191120
What this trial is testing

FAPI Molecular Imaging for Diagnosis of the CMS4 Unfavorable Colorectal Cancer Subtype

Who this might be right for
Metastatic Colorectal CancerMetastatic Cancer to Liver
UMC Utrecht 45
Not applicableUnknownNCT01516710
What this trial is testing

Oslo Randomized Laparoscopic Versus Open Liver Resection for Colorectal Metastases Study

Who this might be right for
Secondary Malignant Neoplasm of LiverColorectal Neoplasms
Oslo University Hospital 280
Early research (Phase 1)Looking for participantsNCT06821048
What this trial is testing

Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerStomach CancerPancreatic Cancer+1 more
Weijia Fang, MD 18
Testing effectiveness (Phase 2)Study completedNCT00006050
What this trial is testing

Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
UNICANCER
Testing effectiveness (Phase 2)Study completedNCT00444678
What this trial is testing

Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerNeoplasm Metastasis
NYU Langone Health 36
Testing effectiveness (Phase 2)Study completedNCT00002933
What this trial is testing

Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
Case Comprehensive Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT03559543
What this trial is testing

Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma

Who this might be right for
Colorectal NeoplasmIntestinal NeoplasmsGastrointestinal Neoplasms+6 more
Catalysis SL 40
Not applicableWithdrawnNCT01012804
What this trial is testing

Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer

Who this might be right for
Colorectal Cancer
Georgetown University
Testing effectiveness (Phase 2)Study completedNCT00044343
What this trial is testing

GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin

Who this might be right for
Colorectal Cancer
GlaxoSmithKline 80
Testing effectiveness (Phase 2)Looking for participantsNCT04899908
What this trial is testing

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Who this might be right for
Brain CancerBrain MetastasesMelanoma+13 more
Brigham and Women's Hospital 134
Early research (Phase 1)WithdrawnNCT02573220
What this trial is testing

Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer

Who this might be right for
Stage IVA Colorectal CancerStage IVB Colorectal Cancer
University of Chicago
Testing effectiveness (Phase 2)Active Not RecruitingNCT05677113
What this trial is testing

QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerLiver Metastases
Sunnybrook Health Sciences Centre 115
Post-approval studies (Phase 4)Ended earlyNCT01468623
What this trial is testing

Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6

Who this might be right for
Colorectal Cancer, Metastatic
Myriad Genetic Laboratories, Inc. 51
Testing effectiveness (Phase 2)Study completedNCT00063960
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 94
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07150403
What this trial is testing

Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Carcinoma (mCRC)
Federation Francophone de Cancerologie Digestive 74
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Testing effectiveness (Phase 2)Study completedNCT01490996
What this trial is testing

Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer

Who this might be right for
Colonic CancerMetastasis
University of Leicester 41
Not applicableUnknownNCT03175146
What this trial is testing

See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely

Who this might be right for
Colonic NeoplasmsNeoplasm Metastasis
AHS Cancer Control Alberta 30
Not applicableStudy completedNCT07650786
What this trial is testing

Cell Membrane Potential Regulates Spatial-Specific Mechanoptosis Resistance and Metastasis in Colorectal Cancer Via Mechanotransduction and the PVR/CD96 Axis

Who this might be right for
Colorectal Cancer
Ma Tianyi 4
Testing effectiveness (Phase 2)Study completedNCT03485027
What this trial is testing

Rechallenge of Prior Regimen in Third or Later-line Chemotherapy in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerChemotherapy Effect
Fudan University 43
Next Page